Bruker posts FY25 GAAP loss of $0.15 per share; guides 2026 non-GAAP EPS $2.10-$2.15
Bruker reported fourth-quarter 2025 revenue of $977.2 million, flat year over year, and non-GAAP diluted EPS of $0.59 versus $0.76 a year earlier. For the full year, revenue rose 2.1% to $3.44 billion, but the company posted a GAAP diluted loss of $(0.15) per share after $127.2 million of goodwill and intangible impairment charges and $77.4 million of restructuring charges. For 2026, Bruker guided to revenue of $3.57 to $3.60 billion and non-GAAP EPS of $2.10 to $2.15.
Key points
- Q4-25 revenue of $977.2 million, down 0.2% year over year; non-GAAP diluted EPS of $0.59 versus $0.76 in Q4-24
- FY25 GAAP diluted loss per share of $(0.15) versus EPS of $0.76 in FY24, reflecting $127.2 million in impairment charges and $77.4 million in restructuring charges
- FY26 guidance: revenue of $3.57 to $3.60 billion and non-GAAP EPS of $2.10 to $2.15, including a currency headwind of about $0.15 per share
- Management said the Q4 margin recovery lagged prior guidance, so cost-savings initiatives were expanded beyond the previous range
The filing
Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 12, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.